4//SEC Filing
Simpson Curran 4
Accession 0001346164-25-000005
CIK 0001590877other
Filed
Oct 9, 8:00 PM ET
Accepted
Oct 10, 6:38 PM ET
Size
5.5 KB
Accession
0001346164-25-000005
Insider Transaction Report
Form 4
REGENXBIO Inc.RGNX
Simpson Curran
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2025-10-09$12.62/sh−20,811$262,635→ 216,162 total
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $12.50 to $12.84. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
REGENXBIO Inc.
CIK 0001590877
Entity typeother
Related Parties
1- filerCIK 0001346164
Filing Metadata
- Form type
- 4
- Filed
- Oct 9, 8:00 PM ET
- Accepted
- Oct 10, 6:38 PM ET
- Size
- 5.5 KB